Glutathione ranks 152 of 373 Peripheral neuropathy treatments based on 4 research articles we have analyzed from 137 relevant articles we identified. The relationship is in the bottom 2% of our analyses.

About Glutathione and Peripheral neuropathy

Peripheral neuropathy (PN) is damage to or disease affecting nerves, which may impair sensation, movement, gland or organ function, or other aspects of health, depending on the type of nerve affected. Common causes include systemic diseases (such as diabetes or leprosy), vitamin deficiency, medication (e.g., chemotherapy), traumatic injury, radiation therapy, excessive alcohol consumption, immune system disease or viral infection. It can also be genetic (present from birth) or idiopathic (no known cause). In conventional medical usage, the word neuropathy (neuro-, "nervous system" and -pathy, "disease of") without modifier usually means peripheral neuropathy.1

Glutathione (GSH) is an important antioxidant in plants, animals, fungi, and some bacteria and archaea, preventing damage to important cellular components caused by reactive oxygen species such as free radicals, peroxides, lipid peroxides and heavy metals. It is a tripeptide with a gamma peptide linkage between the carboxyl group of the glutamate side-chain and the amine group of cysteine (which is attached by normal peptide linkage to a glycine).2

There have been 1,057 reported side effects for Glutathione in the US. The 5 most reported: Toxic anterior segment syndrome, Endophthalmitis, Pyrexia, Alanine aminotransferase increased, Hepatic function abnormal.

The average price we found for Glutathione products was $32.82. The lowest price we found was $1.74

What researchers say about Glutathione as Peripheral neuropathy treatment

Researchers report:

  • Several neuromodulatory agents such as calcium-magnesium infusions; antiepileptic drugs like carbamazepine, gabapentin, and venlafaxine; amifostine; a-lipoic acid; and [Glutathione] have demonstrated some activity in the prophylaxis and treatment of oxaliplatin-induced acute [Peripheral neuropathy].1
  • We retrospectively studied 51 Japanese adults with colorectal cancer who had received oxaliplatin-based chemotherapy to explore the pharmacogenetic association between oxaliplatin-induced [Peripheral neuropathy] and polymorphisms of the excision repair cross-complementation Group 1 (ERCC1) and [Glutathione]-S-transferases pi 1 (GSTP1) genes.2
  • Our data suggest that the combination of age and cutaneous messenger RNA levels of [Glutathione] S-transferase theta 2 and cathepsin A composes a strong indicator of disease severity in patients with Charcot-Marie-Tooth 1A, as quantified by the Charcot-Marie-Tooth [Peripheral neuropathy] Score.3
  • We evaluated the gene expression of [Glutathione] peroxidase, catalase, and superoxide dismutase (cuprozinc and manganese separately) in L4,5 dorsal root ganglion (DRG) and superior cervical ganglion, as well as enzyme activity of [Glutathione] peroxidase in DRG and sciatic nerve in experimental diabetic [Peripheral neuropathy] of 3 months and 12 months durations....Gene expression of [Glutathione] peroxidase, catalase, cuprozinc superoxide dismutase, and manganese superoxide dismutase were not reduced in experimental diabetic [Peripheral neuropathy] at either 3 or 12 months.4

Review all research

More Peripheral neuropathy treatments

Explore all Peripheral neuropathy treatments we have analyzed:

Paclitaxel
8787% Complete
Gemcitabine
7878% Complete
Pregabalin
7777% Complete
Insulin
7777% Complete
Gabapentin
7575% Complete
Amitriptyline
6666% Complete
Norepinephrine
5757% Complete
Lidocaine
5454% Complete
Duloxetine
5252% Complete
Morphine
5252% Complete

All Peripheral neuropathy Treatments 373

Get updates on Glutathione as Peripheral neuropathy treatment

Subscribe to receive notifications by email.

Subscribe

Research last analyzed March 03, 2015 @8:52AM.